Tristetraprolin binds to the 3'-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site
about
sameAs
AU-rich elements and associated factors: are there unifying principles?Herpes simplex virus 1 induces cytoplasmic accumulation of TIA-1/TIAR and both synthesis and cytoplasmic accumulation of tristetraprolin, two cellular proteins that bind and destabilize AU-rich RNAsThe roles of TTP and BRF proteins in regulated mRNA decayAlternative polyadenylation of cyclooxygenase-2.Genome-wide alternative polyadenylation in animals: insights from high-throughput technologiescAMP-dependent posttranscriptional regulation of steroidogenic acute regulatory (STAR) protein by the zinc finger protein ZFP36L1/TIS11bPhosphorylation site analysis of the anti-inflammatory and mRNA-destabilizing protein tristetraprolin.Tissue- and age-dependent expression of RNA-binding proteins that influence mRNA turnover and translationThe mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.Macrophage responses to lipopolysaccharide are modulated by a feedback loop involving prostaglandin E2, dual specificity phosphatase 1 and tristetraprolin.Posttranscriptional Regulation of Cyclooxygenase 2 Expression in Colorectal CancerLeukotriene B(4) BLT receptor signaling regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of Ras/Raf/ERK/p42 AUF1 pathway.Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements.Regulation of cyclooxygenase-2 expression by heat: a novel aspect of heat shock factor 1 function in human cells.Coordinated expression of tristetraprolin post-transcriptionally attenuates mitogenic induction of the oncogenic Ser/Thr kinase Pim-1.Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy.Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin: a zinc-dependent mRNA binding protein affected by posttranslational modifications.Cyclooxygenase-2 is a target of microRNA-16 in human hepatoma cellsRNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative responseTGF-β Suppresses COX-2 Expression by Tristetraprolin-Mediated RNA Destabilization in A549 Human Lung Cancer Cells.Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuliHypoxia-inducible factor-1α mRNA: a new target for destabilization by tristetraprolin in endothelial cells.Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats.Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradationPostgenomic global analysis of translational control induced by oncogenic signaling.Beyond the 3' end: experimental validation of extended transcript isoformsHistone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells.The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.MicroRNA and AU-rich element regulation of prostaglandin synthesisThe role of tristetraprolin in cancer and inflammation.Mechanistic aspects of COX-2 expression in colorectal neoplasiaGenome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolinMSK1 and MSK2 inhibit lipopolysaccharide-induced prostaglandin production via an interleukin-10 feedback loopRole of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation.Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence.The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.Quantitative evaluation of His-tag purification and immunoprecipitation of tristetraprolin and its mutant proteins from transfected human cells.Suppression of IL-12 production by tristetraprolin through blocking NF-kcyB nuclear translocation.Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation
P2860
Q24535929-5646C793-050E-4E24-9F18-C6E2EDA6835CQ24563981-97D68B38-D91B-4FAC-A3D2-92085B594F08Q24633013-D4DBAE68-534D-427F-99DF-FF6EE488C751Q24798039-BDFE2223-6D95-4BB5-A46D-22E825A9C68AQ26992052-2B052C35-C697-429B-BCEE-7D4F67DA0C45Q28118974-6B1F3B43-03AB-41DC-9AC8-44DFBB032330Q33309340-3A0CE608-9AC7-4F8C-94A6-9D2CA852DC5BQ33588805-9EB28213-CAC2-4634-BB7F-37E70A2A222BQ33627886-B6EE838B-573F-4C88-AA99-1C573812718DQ33849200-1DB3F781-E997-4F4D-A135-7EBBF1D548BEQ33924658-F9A9554E-8508-46FD-9DC3-84A569F15B45Q34025186-567EE018-8EB9-48A0-991D-1DD2A469CCD0Q34065213-E54986D7-EB08-4A5E-A37E-9F3171F45F9BQ34162773-D87D6D6C-E20F-49BD-BF33-C431CD955F85Q34193713-E197DEF5-D601-4C6E-A4C9-9C0169A6B916Q34200816-83F77C25-B0B1-4FCF-AAEE-DE3FD1B332B6Q34314339-E60FC9B9-A9DC-4621-9033-A8F556731E6AQ34506147-130BEBDA-B615-4C8F-AD4C-EB6C16D40C86Q34580412-9CD98C4C-4BDF-4576-9356-FFEE446C80A8Q34977232-B0BB9D43-748B-4302-9428-814E22B094C8Q35207107-E97903E6-FF79-4772-A50F-9C6B8DDFD800Q35210986-79CE2211-E217-4214-B12D-7D33E7DDAC1DQ35613550-92873E26-DFF2-451E-B6E4-AE7D3D45D946Q35660728-B164B6AE-2E16-491D-AAA3-D22AE00A9805Q35750140-FA44A1C3-D7BA-460E-852F-5D3A3E21FD13Q35804602-F5E1C336-61E6-4713-95AE-103DA58668CAQ36139104-ADAC080C-856B-49E5-A933-CB3CECCF09F1Q36174568-7C58ED7D-7F4D-442C-93E3-8187773402CDQ36249379-7EAD525A-AA25-4ADE-8694-7E4898AA4B66Q36290434-4C1A9EBC-27D1-41A5-9AE3-403B23B1992FQ36336831-17B4BE7D-2D62-4E0E-B73E-62CF5198CA6AQ36727319-8AE4D1B1-5A96-4852-9482-84614A41E115Q36759864-D94BF74D-76D9-4699-9668-64D6F96A81B7Q36826366-42D48A7D-38CA-4D69-B349-E525E6EB34B1Q37051346-A3BE7917-057C-4F57-B812-50D8FAAAD415Q37092393-9D15CD9B-BDE1-46AE-8734-E78C4AF07841Q37119721-0EFB61F3-BDDF-4916-BC47-0DA9D5F99CABQ37188171-F295E7B3-1739-4715-91B7-3404920560BFQ37210848-8CAE7F3C-A6CD-43FD-8804-2805E9091B86Q37235358-2B469A84-100B-4FBC-85F6-07EFE465A4CA
P2860
Tristetraprolin binds to the 3'-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tristetraprolin binds to the 3 ...... ll line lacks the binding site
@ast
Tristetraprolin binds to the 3 ...... ll line lacks the binding site
@en
Tristetraprolin binds to the 3 ...... ll line lacks the binding site
@nl
type
label
Tristetraprolin binds to the 3 ...... ll line lacks the binding site
@ast
Tristetraprolin binds to the 3 ...... ll line lacks the binding site
@en
Tristetraprolin binds to the 3 ...... ll line lacks the binding site
@nl
prefLabel
Tristetraprolin binds to the 3 ...... ll line lacks the binding site
@ast
Tristetraprolin binds to the 3 ...... ll line lacks the binding site
@en
Tristetraprolin binds to the 3 ...... ll line lacks the binding site
@nl
P2093
P2860
P356
P1476
Tristetraprolin binds to the 3 ...... ll line lacks the binding site
@en
P2093
Dan A Dixon
Hitoshi Sawaoka
John A Oates
Olivier Boutaud
P2860
P304
P356
10.1074/JBC.M300016200
P407
P577
2003-04-18T00:00:00Z